Screening of a library of phage-displayed peptides identifies human Bcl-2 as a Taxol-binding protein

Journal of Molecular Biology

Volumn 285, Issue 1, 1999, Pages 197-203

  Rodi, Diane J ^a   Janes, Robert W ^b,c   Sanganee, Hitesh J ^a   Holton, Robert A ^a   Wallace, B A ^c   Makowski, Lee ^a  

^a FLORIDA STATE UNIVERSITY   (United States)

^b QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^c UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Apoptosis; Bcl 2; Paclitaxel; Phage display

Indexed keywords

PACLITAXEL; PROTEIN BCL 2; TUBULIN;

APOPTOSIS; ARTICLE; BACTERIOPHAGE; BINDING AFFINITY; CIRCULAR DICHROISM; CONFORMATIONAL TRANSITION; DRUG MECHANISM; DRUG PROTEIN BINDING; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HUMAN; NONHUMAN; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SPECTROSCOPY;

ESCHERICHIA COLI;

EID: 0033534641     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmbi.1998.2303     Document Type: Article

References (30)

1. Aime-Sempe C., Kitada S., Reed J. C. Investigations of paclitaxel-mediated phosphorylation of Bcl-2. Blood. 88:1996;106.
2. Land Bcl-2. EMBO J. 16:1997;968-977.
3. Donaldson K. L., Goolsby G. L., Kiener P. A., Wahl A. F. Activation of p34cdc2 coincident with paclitaxel-induced apoptosis. Cell. Growth Differ. 5:1994;1041-1050.
4. Dunker A. K., Garner E., Guilliot S., Romero P., Albrecht K., Hart J., Obradovic Z., Kissinger C., Villagranca J. E. Protein disorder and the evolution of molecular recognition: theory, predictions and observations. Pac. Symp. Biocomp. 3:1998;473-484.
5. Fang G., Chang B. S., Kim C. N., Perkins C., Thompson C. B., Bhalla K. N. "Loop" domain is necessary for taxol-induced mobility shift and phosphorylation of Bcl-2 as well as for inhibiting taxol-induced cytosolic accumulation of cytochrome c and apoptosis. Cancer Res. 58:1998;3202-3208.
6. Gallager R. G. Information Theory and Reliable Communication. 1968;John Wiley & Sons, New York.
7. Haldar S., Jena N., Croce C. M. Inactivatin of Bcl-2 by phosphorylation. Proc. Natl Acad. Sci. USA. 92:1995;4507-4511.
8. Haldar S., Chintapalli J., Croce C. M. Paclitaxel induces Bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56:1996;1253-1255.
9. Haldar S., Basu A., Croce C. M. Bcl2 is the guardian of microtubule integrity. Cancer Res. 57:1997;229-233.
10. Haldar S., Basu A., Croce C. M. Serine-70 is one of the critical sites for drug-induced Bc12 phosphorylation in cancer cells. Cancer Res. 58:1998;1609-1615.
11. Loverexpression inhibits paclitaxel-inducing Yama protease activity and apoptosis. Cell. Growth Differ. 7:1996;1087-1094.
12. Ito T., Deng X., Carr B., May W. S. Bcl-2 phosphorylation required for anti-apoptosis function. J. Biol. Chem. 272:1997;11671-11673.
13. Jordan M. A., Wendell K., Gardiner S., Derry W. B., Copp H., Wilson L. Mitotic block induced in HeLa cells by low concentrations of paclitaxel (Paclitaxel) results in abnormal mitotic exit and apoptotic cell death. Cancer Res. 56:1996;816-825.
14. Kay B. K., Winter J., McCafferty J. Phage Display of Peptides and Proteins: A Laboratory Manual. 1996;Academic Press, San Diego.
15. Lieu C. H., Yang Y. N., Lai Y. K. Dual cytotoxic mechanisms of submicromolar taxol on human leukemia HL-60 cells. Biochem. Pharmacol. 53:1997;1587-1596.
16. Makowski L., Russel M. Structure and assembly of filamentous bacteriophages. Chiu W., Burnett R. M., Garcea R. L. Structural Biology of Viruses. 1997;352-380 Oxford University Press.
17. Maundrell K., Antonsson B., Magnenat E., Camps M., Muda M., Chabert C., Gillieron C., Boschert U., Vial-Knecht E., Martinou J. C., Arkinstall S. Bcl-2 undergoes phosphorylation by c-Jun N-terminal Kinase/Stress-activated protein kinases in the presence of the constitutively active GTP-binding protein Rac1. J. Biol. Chem. 272:1997;25238-25246.
18. Mielke D. L., Wallace B. A. Secondary structural analyses of the nicotinic acetylcholine receptor as a test of molecular models. J. Biol. Chem. 263:1988;3177-3182.
19. Milross C. G., Mason K. A., Hunter N. R., Chung W.-K., Peters L. J., Milas L. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J. Natl Cancer Inst. 88:1996;1308-1314.
20. L, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
21. Nogales E., Wolf S. G., Downing K. H. Structure of the αβ tubulin dimer by electron crystallography. Nature. 391:1998;199-203.
22. Reed J. C. Bcl-2 family proteins: strategies for overcoming chemoresistance in cancer. Kaufmann S. H. Apoptosis: Pharmacological Implications and Therapeutic Opportunities. 1997;501-532 Academic Press, San Diego.
23. Reed J. C., Tanaska S. T. Somatic point mutations in translocated bcl-2 alleles of non-Hodgkin's lymphomas and lymphocytic leukemias: implications for mechanism of tumor progression. Leuk. Lymphoma. 10:1993;157-163.
24. Rodi D. J., Makowski L. Transfer RNA isoacceptor availability contributes to sequence censorship in a library of phage displayed peptides. Namba K. Structure and Function of Macromolecular Assembly. 1997;155-164 Matsushita Electric Industrial Co.Ltd.
25. Romero P., Obradovic Z., Kissinger C. R., Villafranca J. E., Garner E., Guilliot S., Dunker A. K. Thousands of proteins likely to have disordered regions. Pac. Symp. Biocomp. 3:1998;437-448.
26. Schiff P. B., Fant J., Horwitz S. B. Promotion of microtubule assembly in vitro by taxol. Nature. 277:1979;665-667.
27. Scott J. K., Smith G. P. Searching for peptide ligands with an epitope library. Science. 249:1990;386-390.
28. Uhlmann E. J., D'Sa-Eipper C., Subramanian T., Wagner A. J., Hay N., Chinnadurai G. Deletion of a non-conserved region of Bcl-2 confers a novel gain of function: suppression of apoptosis with concomitant cell proliferation. Cancer Res. 56:1996;2506-2509.
29. Wallace B. A., Teeters C. L. Differential absorption flattening optical effects are significant in the circular dichroism spectra of large membrane fragments. Biochemistry. 26:1987;65-70.
30. Woods C. M., Zhu J., McQueney P. A., Bollag D., Lazarides E. Paclitaxel-induced mitotic block triggers rapid onset of a p53-independent apoptotic pathway. Mol. Med. 1:1995;506-526.